News: Legal and Regulatory
Latest in Legal and Regulatory
Shire has received European Commission marketing authorisation for VPRIV (velaglucerase alfa), a human cell line derived enzyme replacement therapy for the long-term treatment of type 1 Gaucher disease.
31 August 2010
US District Judge Halts Stem Cell Funding
25 August 2010
25 August 2010
Cumberland Hit by Acetadote Review Delay
24 August 2010
24 August 2010
US Announces Sweeping Review of Medical Countermeasures
20 August 2010
20 August 2010
US Senate Passes Improving Access to Clinical Trials Act
11 August 2010
11 August 2010
Merck Investigated on Alleged Bribery Law Violations
10 August 2010
10 August 2010
AstraZeneca Settles Over Seroquel Liability
09 August 2010
09 August 2010
FDA Could Receive New Recall Powers
06 August 2010
06 August 2010
FDA Approves Chronic Drooling Treatment
02 August 2010
02 August 2010
FDA Gives Cladribine Priority Review Treatment
30 July 2010
30 July 2010
